Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
tizanidine (Zanaflex)
print preview
bookmark
share with colleague
General Information
Company
Acorda Therapeutics Inc.
Description
Adrenergic receptor alpha 2 (ADRA2) agonist
Molecular Target
Adrenergic receptor alpha 2 (ADRA2)
Mechanism of Action
Adrenergic receptor alpha 2 (ADRA2) agonist
Latest Stage of Development
Marketed
Indication
Spasticity
Partner
Elan Corp. plc
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy